Loading…
OrbusNeich held a groundbreaking ceremony for its new R&D and production base in Fuyang, Hangzhou, China, with fixed asset investment of approximately RMB 300-400 million. The facility will have a gross floor area of 60,000 m² and focus on PCI and PTA interventional products.
“The groundbreaking ceremony of our new R&D and production base in Hangzhou marks another important milestone in the business development.”orbusneich.com
Summarized from public sources; check the original articles before acting on it.